NASDAQ
BriaCell Therapeutics Corp. (BCTX) has a free cash flow growth of 24.15% as of Friday, May 29, 2026. This represents a 760.43% increase compared to its 12-month average of -3.66%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.